(Q36609877)

English

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

scientific article published on 6 February 2007

Statements

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma (English)
D M Shaw
N B Connolly
P M Patel
S Kilany
G Hedlund
O Nordle
G Forsberg
J Zweit
P L Stern
R E Hawkins
6 February 2007
567-574

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit